Chris Loh practices complex patent litigation in the areas of pharmaceuticals, biotechnology, and chemistry. As lead or co-counsel, Chris has litigated patent cases involving oncology therapies, anti-HIV therapies, anti-hepatitis drugs, antidepressants, and statins. He has argued before numerous federal district courts and the United States Court of Appeals for the Federal Circuit, and has won in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), on behalf of patent owners.
In addition to his litigation work, Chris counsels clients on transactional and patent prosecution issues concerning both small-molecule drugs and biological products, such as recombinant antibodies. He also provides advice on a range of intellectual property matters, including inventorship, trade secrets, and licensing.